Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $1.33 Million - $1.56 Million
17,868 New
17,868 $1.36 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $319,558 - $361,483
-3,989 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $212,161 - $234,602
2,662 Added 200.6%
3,989 $349,000
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $56,182 - $65,361
-687 Reduced 34.11%
1,327 $109,000
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $2.25 Million - $2.49 Million
-27,384 Reduced 93.15%
2,014 $175,000
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $1.47 Million - $2.07 Million
-20,866 Reduced 41.51%
29,398 $2.42 Million
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $3.7 Million - $4.12 Million
50,264 New
50,264 $4.31 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.